However, in a CRC mouse model carrying a p53 R270H mutation, p53−/− mice showed tumor load, frequency of metastasis, and overall survival similar to that of p53−/− mice that opposed p53 GOF (Tang et al., 2019). Here, TP53 is linked to colorectal carcinoma.